August 18, 2026
1 min read

Nestlé turns GLP-1 weight-loss drug boom into product opportunity

Nestlé is using AI to develop nutrition products addressing GLP-1 side effects like muscle loss and “Ozempic face,” its CTO tells Reuters

Leave a Reply

Your email address will not be published.

Previous Story

Nutrition a key ingredient for Vermont students heading back to school

Next Story

SUMMITS Partners with HYPHEN to Launch Autonomous Precision Nutrition

Previous Story

Nutrition a key ingredient for Vermont students heading back to school

Next Story

SUMMITS Partners with HYPHEN to Launch Autonomous Precision Nutrition

Latest from Blog

Go toTop